Prescription drug · ANDA
Deflazacort Oral Suspension (Deflazacort oral) NDC 70377-188
Deflazacort 22.75 mg/mL · Suspension · Oral · Biocon Pharma Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70377-188-21 | 70377018821 | 1 BOTTLE in 1 CARTON (70377-188-21) / 13 mL in 1 BOTTLEMarketed from Sep 25, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Deflazacort Oral Suspension
- Generic name (nonproprietary)
- deflazacort oral
- Active ingredients
- Deflazacort — 22.75 mg/mL
- Dosage form
- Suspension
- Route
- Oral
- Labeler
- Biocon Pharma Inc.NDC labeler code 70377
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 220709
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 70377-188_3f0a59d0-17a9-264b-9081-b858e4198d98SPL ID 3f0a59d0-17a9-264b-9081-b858e4198d98
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470377018821followed by a unit qualifier and the quantityPackage 70377-0188-21. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 70377-188
- What is NDC 70377-188?
- 70377-188 is the product NDC for Deflazacort Oral Suspension (deflazacort oral), Deflazacort 22.75 mg/mL suspension, listed with the FDA by Biocon Pharma Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Deflazacort Oral Suspension (Deflazacort Oral).
- What is the active ingredient?
- Deflazacort.
- Who is the labeler?
- Biocon Pharma Inc., NDC labeler code 70377. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Deflazacort Oral Suspension?
- 4 other product NDCs are listed under this name. See all Deflazacort Oral Suspension NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Deflazacort Oral Suspension products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Deflazacort Oral Suspensiondeflazacort oral | Deflazacort 22.75 mg/mL | SuspensionOral | Sun Pharmaceutical Industries, Inc. | 57664-993 | 57664-0993-01 |
| Deflazacort Oral Suspensiondeflazacort | Deflazacort 22.75 mg/mL | SuspensionOral | Zydus Pharmaceuticals (USA) Inc. | 70710-2007 | 70710-2007-03 |
| Deflazacort Oral Suspensiondeflazacort | Deflazacort 22.75 mg/mL | SuspensionOral | Doppel Farmaceutici S.r.l. | 81806-200 | 81806-0200-73 |
| Deflazacort Oral Suspensiondeflazacort oral | Deflazacort 22.75 mg/mL | SuspensionOral | Cranbury Pharmaceuticals, LLC | 27808-249 | 27808-0249-01 |